Twelve Live Births After Uterus Transplantation in the Dallas UtErus Transplant Study.


Journal

Obstetrics and gynecology
ISSN: 1873-233X
Titre abrégé: Obstet Gynecol
Pays: United States
ID NLM: 0401101

Informations de publication

Date de publication:
01 02 2021
Historique:
received: 05 10 2020
accepted: 05 11 2020
pubmed: 9 1 2021
medline: 17 4 2021
entrez: 8 1 2021
Statut: ppublish

Résumé

To describe aggregated pregnancy outcomes after uterus transplantation from a single, experienced center. This prospective study reports on live births among 20 women who received a uterus transplant from 2016 to 2019 at Baylor University Medical Center at Dallas. These live births occurred between November 2017 and September 2020. The main measures were live birth, maternal complications, and fetal and newborn outcomes. There were six graft failures (four surgical complications and two with poor perfusion postoperatively). Of the 14 technically successful transplants, at least one live birth occurred in 11 patients. Thus far, the live birth rate per attempted transplant is 55%, and the live-birth rate per technically successful transplant is 79%. Ten uteri were from nondirected living donors and one uterus was from a deceased donor. In vitro fertilization was performed to achieve pregnancy. Ten recipients delivered one neonate, and one recipient delivered two neonates. One organ rejection episode was detected during pregnancy and was resolved with steroids. The median birth weight was 2,890 g (range 1,770-3,140 g [median 68th percentile]). Maternal weight gain was higher than Institute of Medicine recommendations. Maternal medical complications were observed in five recipients (elevated creatinine level, gestational diabetes, gestational hypertension [n=2], and preeclampsia). In five recipients, maternal medical or obstetric complications led to an unplanned preterm delivery (elevated creatinine level, preeclampsia; preterm labor [n=3]). The median gestational age at delivery was 36 6/7 weeks (range 30 6/7-38 weeks). All neonates were liveborn, with Apgar scores of 8 or higher at 5 minutes. Over the first 3 years, our program experienced a live-birth rate per attempted transplant of 55% and a live-birth rate per technically successful transplant of 79%. In our experience, uterus transplantation resulted in a third-trimester live birth in all cases in which pregnancies reached 20 weeks of gestation. Maternal medical and obstetric complications can occur; however, these were manageable by applying principles of generally accepted obstetric practice. ClinicalTrials.gov, NCT02656550.

Identifiants

pubmed: 33416285
doi: 10.1097/AOG.0000000000004244
pii: 00006250-202102000-00007
doi:

Banques de données

ClinicalTrials.gov
['NCT02656550']

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

241-249

Informations de copyright

Copyright © 2021 by the American College of Obstetricians and Gynecologists. Published by Wolters Kluwer Health, Inc. All rights reserved.

Déclaration de conflit d'intérêts

Financial Disclosure The authors did not report any potential conflicts of interest.

Références

Brännström M, Johannesson L, Bokström H, Kvarnström N, Mölne J, Dahm-Kähler P, et al. Livebirth after uterus transplantation. Lancet 2015;385:607–16. doi: 10.1016/S0140-6736(14)61728-1
doi: 10.1016/S0140-6736(14)61728-1
Ejzenberg D, Andraus W, Baratelli Carelli Mendes LR, Ducatti L, Song A, Tanigawa R, et al. Livebirth after uterus transplantation from a deceased donor in a recipient with uterine infertility. Lancet 2019;392:2697–704. doi: 10.1016/S0140-6736(18)31766-5
doi: 10.1016/S0140-6736(18)31766-5
Testa G, McKenna GJ, Gunby RT Jr, Anthony T, Koon EC, Warren AM, et al. First live birth after uterus transplantation in the United States. Am J Transpl 2018;18:1270–4. doi: 10.1111/ajt.14737
doi: 10.1111/ajt.14737
Castellón LAR, Amador MIG, González RED, Eduardo MSJ, Díaz-García C, Kvarnström N, et al. The history behind successful uterine transplantation in humans. JBRA Assist Reprod 2017;21:126–34. doi: 10.5935/1518-0557.20170028
doi: 10.5935/1518-0557.20170028
Jones BP, Saso S, Bracewell-Milnes T, Thum MY, Nicopoullos J, Diaz-Garcia C, et al. Human uterine transplantation: a review of outcomes from the first 45 cases. BJOG 2019;126:1310–9. doi: 10.1111/1471-0528.15863
doi: 10.1111/1471-0528.15863
Flyckt R, Falcone T, Quintini C, Perni U, Eghtesad B, Richards EG, et al. First birth from a deceased donor uterus in the United States: from severe graft rejection to successful cesarean delivery. Am J Obstet Gynecol 2020;223:143–51. doi: 10.1016/j.ajog.2020.03.001
doi: 10.1016/j.ajog.2020.03.001
Brännström M, Enskog A, Kvarnström N, Ayoubi JM, Dahm-Kähler P. Global results of human uterus transplantation and strategies for pre-transplantation screening of donors. Fertil Steril 2019;112:3–10. doi: 10.1016/j.fertnstert.2019.05.030
doi: 10.1016/j.fertnstert.2019.05.030
Johannesson L, Wallis K, Koon EC, McKenna GJ, Anthony T, Leffingwell SG, et al. Living uterus donation and transplantation: experience of interest and screening in a single center in the United States. Am J Obstet Gynecol 2018;218:331.e1–7. doi: 10.1016/j.ajog.2017.11.594
doi: 10.1016/j.ajog.2017.11.594
Järvholm S, Warren AM, Jalmbrant M, Kvarnström N, Testa G, Johannesson L. Preoperative psychological evaluation of uterus transplant recipients, partners, and living donors: suggested framework. Am J Transpl 2018;18:2641–6. doi: 10.1111/ajt.15039
doi: 10.1111/ajt.15039
Warren AM, Testa G, Anthony T, McKenna GJ, Klintmalm GB, Wallis K, et al. Live nondirected uterus donors: psychological characteristics and motivation for donation. Am J Transpl 2018;18:1122–8. doi: 10.1111/ajt.14670
doi: 10.1111/ajt.14670
Johannesson L, Wall A, Putman JM, Zhang L, Testa G, Diaz-Garcia C. Rethinking the time interval to embryo transfer after uterus transplantation—DUETS (Dallas UtErus Transplant Study). BJOG 2019;126:1305–9. doi: 10.1111/1471-0528.15860
doi: 10.1111/1471-0528.15860
American College of Obstetricians and Gynecologists, Task Force on Hypertension in Pregnancy. Hypertension in pregnancy. Report of the American College of Obstetricians and Gynecologists’ Task Force on Hypertension in Pregnancy. 2013;122:1122–31. doi: 10.1097/01.AOG.0000437382.03963.88
doi: 10.1097/01.AOG.0000437382.03963.88
Carpenter MW, Coustan DR. Criteria for screening tests for gestational diabetes. Am J Obstet Gynecol 1982;144:768–73. doi: 10.1016/0002-9378(82)90349-0
doi: 10.1016/0002-9378(82)90349-0
Institute of Medicine and National Research Council Committee to Reexamine IOM Pregnancy Weight Guidelines. Rasmussen KM, Yaktine AL, editors. Weight gain during pregnancy: reexamining the guidelines. National Academies Press; 2009
Moore TR, Cayle JE. The amniotic fluid index in normal human pregnancy. Am J Obstet Gynecol 1990;162:1168–73. doi: 10.1016/0002-9378(90)90009-V
doi: 10.1016/0002-9378(90)90009-V
Hossain R, Harris T, Lohsoonthorn V, Williams MA. Risk of preterm delivery in relation to vaginal bleeding in early pregnancy. Eur J Obstet Gynecol Reprod Biol 2007;135:158–63. doi: 10.1016/j.ejogrb.2006.12.003
doi: 10.1016/j.ejogrb.2006.12.003
Fenton TR, Kim JH. A systematic review and meta-analysis to revise the Fenton growth chart for preterm infants. BMC Pediatr 2013;13:59. doi: 10.1186/1471-2431-13-59
doi: 10.1186/1471-2431-13-59
Chou JH, Roumiantsev S, Singh R. PediTools electronic growth chart calculators: applications in clinical care, research, and quality improvement. J Med Internet Res 2020;22:e16204. doi: 10.2196/16204
doi: 10.2196/16204
World Health Organization. Birthweight percentiles for full-term infants. Accessed November 10, 2020. https://www.infantchart.com/
Testa G, Koon EC, Johannesson L, McKenna GJ, Anthony T, Klintmalm GB, et al. Living donor uterus transplantation: a single center’s observations and lessons learned from early setbacks to technical success. Am J Transpl 2017;17:2901–10. doi: 10.1111/ajt.14326
doi: 10.1111/ajt.14326
Weight gain during pregnancy. Committee Opinion No. 548. American College of Obstetricians and Gynecologists. Obstet Gynecol 2013;121:210–2. doi: 10.1097/01.AOG.0000425668.87506.4c
doi: 10.1097/01.AOG.0000425668.87506.4c
Chmel R, Novackova M, Janousek L, Matecha J, Pastor Z, Maluskova J, et al. Revaluation and lessons learned from the first 9 cases of a Czech uterus transplantation trial: four deceased donor and 5 living donor uterus transplantations. Am J Transpl 2019;19:855–64. doi: 10.1111/ajt.15096
doi: 10.1111/ajt.15096
Chmel R, Pastor Z, Novackova M, Matecha J, Cekal M, Fronek J. Clinical pregnancy after deceased donor uterus transplantation: lessons learned and future perspectives. J Obstet Gynaecol Res 2019;45:1458–65. doi: 10.1111/jog.13992
doi: 10.1111/jog.13992
Johannesson L, Kvarnström N, Mölne J, Dahm-Kähler P, Enskog A, Diaz-Garcia C, et al. Uterus transplantation trial: 1-year outcome. Fertil Steril 2015;103:199–204. doi: 10.1016/j.fertnstert.2014.09.024
doi: 10.1016/j.fertnstert.2014.09.024
Kainz A, Harabacz I, Cowlrick IS, Gadgil SD, Hagiwara D. Review of the course and outcome of 100 pregnancies in 84 women treated with tacrolimus. Transplantation 2000;70:1718–21. doi: 10.1097/00007890-200012270-00010
doi: 10.1097/00007890-200012270-00010
Nevers W, Pupco A, Koren G, Bozzo P. Safety of tacrolimus in pregnancy. Can Fam Physician 2014;60:905–6.
Harel Z, McArthur E, Hladunewich M, Dirk JS, Wald R, Garg AX, et al. Serum creatinine levels before, during, and after pregnancy. JAMA 2019;321:205–7. doi: 10.1001/jama.2018.17948
doi: 10.1001/jama.2018.17948

Auteurs

Liza Johannesson (L)

Annette C. and Harold C. Simmons Transplant Institute, the Fertility Center of Dallas, the Department of Obstetrics and Gynecology, and the Department of Neonatology, Baylor University Medical Center, and the Fetal Care Center, Dallas, Texas; and the Department of Obstetrics and Gynecology, PRISMA Health-University of South Carolina School of Medicine, Columbia, South Carolina.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH